Governance and organizational structure

Board of Directors

The Board of Directors is comprised of representatives of Shareholders of the Fund. The Board bears general responsibility for all aspects for the administration and management of the business of the Fund. In particular, the Board of Directors is in charge of (but not limited to) the following:

  • Determine the business policy of the Fund within the framework of, and to approve major business issues in accordance with, the mission statement as set out by the General Meeting of Shareholders, the Issue Document and the Fund’s constituent documents
  • Take or, as the case may be, supervise investment decisions
  • Ensure that funding is honored and the cash and other investments are managed wisely
  • Approve the contributions of the Fund to the TA Facility
  • Oversee the Investment Manager, approve reports on the business operations of the Fund and approve the financial statements

Directors of the Fund:

Laure Wessemius-Chibrac

Michael Brill

Claudia Huber

Yekbun Gurgoz

Edwige Takassi

Investment Committee

The Investment Committee is comprised of four voting members. The Investment Committee bears general responsibility in relation to the investment decisions of the Fund and oversees the Investment Manager in ensuring the Fund is compliant at all times with the Investment Guidelines.

Members of the Investment Committee:

Claudia Huber

Fodé Bangoura

Jana L. Lessenich, CFA

Albert Hofsink

Investment Manager

Since 2004, Symbiotics Asset Management has been the forefront of emerging markets impact investing, with nearly USD 3 billion in Assets under Management.
Symbiotics Asset Management customizes portfolios and collaborate with asset managers to launch and expand private credit funds globally through impact, featuring fixed-income funds and blended finance solutions. It is one of four distinct business lines, all fully owned by Symbiotics Group.

Symbiotics has been active in Sub-Saharan Africa since 2009 through its South African subsidiary, partnering with 100 financial institutions in 26 countries.
The investment company values are focused on the principles of independence, integrity and innovation: independence towards clients and partners with regards to investment strategies and choices, integrity of staff and work, and innovation in products and services.

Symbiotics initially started its operations in 2004, as a research, origination, and consulting company for microfinance investments. It quickly became a market leader, working for most of the main investment funds in the industry, channelling up to 30% of their total foreign private investments. Today, Symbiotics Group stands out as the only independent firm among the top impact investing companies.

Organizational structure